Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Autonomic Nervous System Disease: early-phase trial registry

2 of 3 indexed Autonomic Nervous System Disease trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Autonomic Nervous System Disease: 3 US clinical trials tracked, 2 recruiting.

Autonomic Nervous System Disease is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Virginia Commonwealth University, running 1 of these trials.

Enrollment posture brief

Registry condition autonomic-nervous-system-disease

OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Autonomic Nervous System (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Autonomic Nervous System Disease

Autonomic Nervous System Disease lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Autonomic Nervous System Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Autonomic Nervous System Disease is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Autonomic Nervous System Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Acoustic vagal nerve stimulation (aVNS) treatment Other
1 trials
Percutaneous vagal nerve stimulation (pVNS) device Device
1 trials
Patient Global Impression of Change (PGIC) Behavioral
1 trials
Quantitative Sleep Measures Behavioral
1 trials
Pittsburgh Sleep Quality Index (PSQI) Behavioral
1 trials
NSI Behavioral
1 trials
HRV Coherence Ratio Other
1 trials

US sites by state

Facility locations filed on Autonomic Nervous System Disease trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Virginia 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Autonomic Nervous System Disease page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autonomic Nervous System Disease condition card totals 3 registered trials; most-linked intervention Acoustic vagal nerve stimulation (aVNS) treatment; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.